Why Nanopartocles Are the Most Commonly Used Form of Silver in Cosmetic and Medicinal Products?
References
- www.wikipedia cited on Dec 29.2024.
- J.L Sagripanti „ Metal-based formulations with high microbicidal activity”. Applied and environmental microbiology. 58(9), 1992: 3157–3162.
- L.G. Ovington „The truth about silver”. Ostomy Wound Manage, 50, 2004: 1-10.
- U.Samuel, J. Guggenbichler „Prevention of catheter-related infections: The potential of a new nano-silver impregnated catheter”. International journal of antimicrobial agents, 23 (1), 2004: 75-8.
- A.D. Russell, W.B. Hugo „Antimicrobial activity and action of silver”. Progress in medicinal chemistry, 31, 1994:351–370.
- S.L. Percival, P.G. Bowler, D. Russell ” Bacterial resistance to silver in wound care”. The Journal of hospital infection, 60(1), 2005: 1–7.
- J.M. Schierholz, L.J. Lucas, A. Rump,G. Pulverer” Efficacy of silvercoated medical devices”. The Journal of hospital infection, 40(4),1998: 257–262.
- J.M. Hamilton-Miller,S. Shah „A microbiological assessment of silver fusidate, a novel topical antimicrobial agent”. International journal of antimicrobial agents, 7(2), 1996:. 97–99.
- C.Thornton Spann,S.C. Taylor, J.M. Weinberg „Topical antimicrobial agents in dermatology”. Clinics in dermatology, 21(1),2003: 70–77.
- R. Mądry, J. Struzyna „Zastosowanie opatrunków srebrowych w leczeniu oparzeń i odmrożeń, zespołu Lyella oraz ran przewlekłych”. Chirurgia Plastyczna i Oparzenia /Plastic Surgery & Burns. 8, 2020: 115-122. (In Polish).
- Y. Huang, X Li, Z Liao, G Zhang, Q. Liu, J. Tang, Y. Peng, X. Liu, Q. Luo „A randomized comparative trial between Acticoat and SD-Ag in the treatment of residual burn wounds, including safety analysis. „Burns : journal of the International Society for Burn Injuries, 33(2), 2007: 161–166.
- G. Bugla-Płoskońska, A. Leszkiewicz „Biologiczna aktywność srebra i jego zastosowanie w medycynie”. Kosmos, 56(1–2), 2007. 115–122. (in Polish).
- M. Bosetti, A. Massè, E. Tobin, M. Cannas „Silver coated materials for external fixation devices: in vitro biocompatibility and genotoxicity”. Biomaterials, 23(3), 2002: 887–892.
- J.A. Szymańska, M. Sala „Wybrane metale i ich związki stosowane w formach farmaceutycznych i kosmetycznych: złoto i srebro”. Bromatologia i Chemia Toksykologiczna. 3,2007: 260-268.
- A. Kotarska „Metalotioneiny w procesie starzenia się mózgu i w chorobach neurozwyrodnieniowych”. Geriatria, 7, 2013:231-237. (in Polish).
- Wikipedia [online], [Cited on: May 16. 2024]. https://commons.wikimedia.org/wiki/Category:Argyria_%28illness%29?uselang=pl#/media/File:Argyria_2b.jpg.
- A.P. Moss, A Sugar, N. A., Hargett, A. Atkin, M. Wolkstein, K.D. Rosenman „The ocular manifestations and functional effects of occupational argyrosis”. Archives of ophthalmology . 97(5), 1979:. 906–908.
- U. Schlötzer-Schrehardt, L.M. Holbach, C. Hofmann-Rummelt, G.O. Naumann „ Multifocal corneal argyrosis after an explosion injury”. Cornea, 20(5), 2001:553–557.
- A.Wadhera, M. Fung „Systemic argyria associated with ingestion of colloidal silver”. Dermatology online journal, 11(1), 2005: 12.
- M. Rai, S.D. Deshmukh, A.P. Ingle, I.R. Gupta, M. Galdiero,S. Galdiero „Metal nanoparticles: The protective nanoshield against virus infection”. Critical Reviews in Microbiology, 42(1), 2016: 46–56.
- N.G. Portney, M. Ozkan „-Oncology: drug delivery, imaging, and sensing”. Analytical and bioanalytical chemistry, 384(3), 2006: 620–630.
- L. Lu, R.W. Sun,R. Chen,C.K. Hui, C.M. Ho, C. M., J.M. Luk,G.K. Lau,C.M. Ch” Silver nanoparticles inhibit hepatitis B virus replication”. Antiviral therapy, 13(2),2008: 253–262.
- J.L. Elechiguerra, J.L. Burt, J.R. Morones, A.Camacho-Bragado, X. Gao, H.H. Lara,M.J. Yacaman “ Interaction of silver nanoparticles with HIV- 1”. Journal of nanobiotechnology. 3, 2005: 6-10.
- D. Baram-Pinto, S. Shukla, N. Perkas, A. Gedanken, R. Sarid „Inhibition of herpes simplex virus type 1 infection by silver nanoparticles capped with mercaptoethane sulfonate”. Bioconjugate chemistry, 20(8), 2009:1497–1502.
- P. Mehrbod, N. Motamed, M. Tabatabaian, R. Estyar, E. Amini, M. Shahidi, M. Kheiri „In Vitro Antiviral Effect of “Nanosilver” on Influenza Virus”. DARU Journal of Pharmaceutical Sciences. 17, 2009: 88-93.
- J. Talapko, T. Matijević, M. Juzbašić, A. Antolović-Požgain, I. Škrlec I.” Antibacterial Activity of Silver and Its Application in Dentistry, Cardiology and Dermatology”. Microorganisms. 8,2020: 70-75.
- J. Rzeszutek, M. Matysiak - Kucharek, M. Czajka, K. Sawicki, P. Rachubik, M. Kruszewski, L. Kapka „Zastosowanie nanocząstek i nanomateriałów w medycynie”. Hygeia Public Health. 4,2014:449-457.
- A. Kędziora, K. Sobik „Oporność bakterii na srebro-problem stary czy nowy?”. Kosmos 62(4), 2013: 557-570.
Language: English
Page range: 65 - 72
Submitted on: Jan 27, 2025
Accepted on: Feb 13, 2025
Published on: Sep 5, 2026
Published by: Polish Hyperbaric Medicine and Technology Society
In partnership with: Paradigm Publishing Services
Related subjects:
© 2026 Anna Kulik, Marta Łuczywek, Barbara Nieradko-Iwanicka, published by Polish Hyperbaric Medicine and Technology Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.